![Artificial Intelligence Advances CNS Autoimmune Disease Care]()
Artificial Intelligence Advances CNS Autoimmune Disease Care
Oct 24,26 | 01:36 EST
Artificial intelligence (AI) is being increasingly investigated for its potential to revolutionize the diagnosis, monitoring, and prognostic assessment of central nervous system (CNS) autoimmune diseases. A new review highlights AI applications across various conditions, including multiple sclerosis, neuromyelitis optica spectrum disorder, autoimmune encephalitis, and myelin oligodendrocyte glycoprotein antibody associated disease. These diseases pose significant diagnostic and therapeutic challenges due to their overlapping clinical presentations, limitations in current biomarkers, and the necessity for extensive long-term patient follow-up. AI has been explored for several clinical functions such as automated neuroimaging analysis, assisting with differential diagnosis, disease classification, predicting relapses, stratifying prognosis, and informing care planning. The technology's reach extends to integrating laboratory data, electronic health records, molecular information, and diverse multimodal patient datasets. Key findings from the review indicate that AI was evaluated across CNS autoimmune diseases to support diagnosis and prognosis, showing the strongest evidence and progress in multiple sclerosis, particularly in imaging and monitoring. While promising, future AI tools aiming to improve risk stratification will require substantial further validation.
... read more
